title: Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells.
authors.affiliation: Ruder Bosković Institute, Zagreb, Croatia. cimbora@irb.hr
authors.forename: Tamara
authors.initials: T
authors.lastname: Cimbora-Zovko
authors.forename: Gerhard
authors.initials: G
authors.lastname: Fritz
authors.forename: Nevenka
authors.initials: N
authors.lastname: Mikac
authors.forename: Maja
authors.initials: M
authors.lastname: Osmak
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000494:pharmacology*; D015536:Down-Regulation; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D020743:rhoB GTP-Binding Protein / Q000032:analysis / Q000037:antagonists & inhibitors / Q000502:physiology*
chemical_list: D000970:Antineoplastic Agents; D020743:rhoB GTP-Binding Protein; D002945:Cisplatin